SKI Market

Indian Indices

Nifty

22,907.60 73.30
(0.32%)

Sensex

76,003.92 554.87
( 0.74%)

Bank Nifty

49,702.60 388.10
( 0.79%)

Nifty IT

36,223.50 -395.85
( -1.08%)

Global Indices

Nasdaq

41,985.63 383.32
(0.92%)

Dow Jones

5,690.25 -0.25
(0.00%)

Hang Seng

37,858.63 13.21
(0.03%)

Nikkei 225

8,718.48 13.25
(0.15%)

Forex

USD-INR

86.61 -0.19
(-0.22%)

EUR-INR

94.64 0.03
(0.03%)

GBP-INR

112.48 -0.04
(-0.04%)

JPY-INR

0.58 0.00
(-0.67%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Jenburkt Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524731

INE354A01013

357.4658419

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

14.05

441.11

EPS(TTM)

Face Value()

Div & Yield %

71.16

1.53

Particulars(INCOME)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)	Mar 2019 ( Cr)
Sales Turnover	141.97	136.75	123.98	109.29	118.89	122.64
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	141.97	136.75	123.98	109.29	118.89	122.64
Other Income	4.67	5.12	4.95	4.31	4.22	3.41
Stock Adjustments	0.39	-1.34	2.28	-3.18	0.49	2.49
Total Income	147.03	140.53	131.21	110.42	123.60	128.54
EXPENDITURE :
Raw Materials	30.80	31.67	33.72	26.91	33.55	38.75
Power & Fuel Cost	0.75	0.76	0.61	0.50	0.59	0.59
Employee Cost	42.49	38.81	36.49	32.38	36.51	31.20
Other Manufacturing Expenses	3.58	4.28	3.85	2.50	2.98	1.23
Selling & Administrative Expenses	31.04	29.03	24.32	23.03	25.46	28.10
Miscellaneous Expenses	0.58	0.50	0.01	0.95	0.54	0.30
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	109.24	105.05	99.01	86.26	99.63	100.18
Operating Profit	37.79	35.49	32.20	24.15	23.97	28.38
Interest	0.27	0.37	0.43	0.47	0.53	0.39
Gross Profit	37.52	35.12	31.77	23.68	23.44	27.99
Depreciation	2.34	2.26	1.90	2.04	2.30	1.35
Profit Before Tax	35.18	32.86	29.87	21.64	21.14	26.64
Tax	9.72	8.48	7.28	5.53	5.90	7.14
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.52	-0.23	0.30	-0.39	0.37	-0.31
Reported Net Profit	25.98	24.61	22.30	16.50	14.87	19.80
Extraordinary Items	0.04	0.00	0.14	0.00	0.00	-0.02
Adjusted Net Profit	25.94	24.61	22.16	16.50	14.87	19.82
Adjustment below Net Profit	0.00	-14.34	0.00	0.00	-1.60	-0.57
P & L Balance brought forward	113.11	108.53	90.91	74.41	69.42	53.27
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	4.96	5.69	4.68	0.00	8.28	3.09
P & L Balance carried down	134.12	113.10	108.53	90.91	74.41	69.42
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	153.00	144.00	120.00	102.00	81.00	102.00
Dividend Per Share(Rs)	15.30	14.40	12.00	10.20	8.10	10.20
Earnings Per Share-Unit Curr	58.86	55.76	48.58	35.96	32.40	43.14
Earnings Per Share(Adj)-Unit Curr	58.86	55.76	48.58	35.96	32.40	43.14
Book Value-Unit Curr	328.42	277.32	255.77	214.55	174.32	168.79
Book Value(Adj)-Unit Curr	328.42	277.32	255.77	214.55	174.32	168.79

22,907.60 73.30 (0.32%)

76,003.92 554.87 ( 0.74%)

49,702.60 388.10 ( 0.79%)

36,223.50 -395.85 ( -1.08%)

41,985.63 383.32 (0.92%)

5,690.25 -0.25 (0.00%)

37,858.63 13.21 (0.03%)

8,718.48 13.25 (0.15%)

86.61 -0.19 (-0.22%)

94.64 0.03 (0.03%)

112.48 -0.04 (-0.04%)

0.58 0.00 (-0.67%)